Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.
Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virus
Journal article
Lin G-L. et al, (2024), Nature Communications, 15
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
Journal article
Frater J. et al, (2021), The Lancet HIV, 8, e474 - e485
Natural and vaccine-induced antibody and cellular responses against emerging SARS-CoV-2 variants of concern
Journal article
Skelly DT. et al, (2021)
Illumina and Nanopore methods for whole genome sequencing of hepatitis B virus (HBV)
Journal article
McNaughton AL. et al, (2019), Scientific Reports, 9
Resistance analysis of genotype 3 hepatitis C virus indicates subtypes inherently resistant to nonstructural protein 5A inhibitors
Journal article
Smith D. et al, (2019), Hepatology, 69, 1861 - 1872
Characterization of hepatitis C virus resistance to grazoprevir reveals complex patterns of mutations following on-treatment breakthrough that are not observed at relapse
Journal article
Bonsall D. et al, (2018), Infection and Drug Resistance, Volume 11, 1119 - 1135
Rolling circle amplification and nanopore-based deep sequencing of full-length HBV genomes
Conference paper
Mcnaughton A. et al, (2018), Journal of Hepatology, 68, S762 - S762
A Novel Vaccine Strategy Employing Serologically Different Chimpanzee Adenoviral Vectors for the Prevention of HIV-1 and HCV Coinfection.
Journal article
Hartnell F. et al, (2018), Frontiers in immunology, 9
The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes
Journal article
von Delft A. et al, (2018), Vaccine, 36, 313 - 321
Immune responses in DAA treated chronic hepatitis C patients with and without prior RG-101 dosing
Journal article
van der Ree MH. et al, (2017), Antiviral Research, 146, 139 - 145
Immune phenotype and function of natural killer and T cells in chronic hepatitis C patients who received a single dose of anti-MicroRNA-122, RG-101
Journal article
Stelma F. et al, (2017), Hepatology, 66, 57 - 68
Characterization of the Specificity, Functionality, and Durability of Host T-Cell Responses Against the Full-Length Hepatitis E Virus
Journal article
Brown A. et al, (2016), Hepatology, 64, 1934 - 1950
Comparison of Next-Generation Sequencing Technologies for Comprehensive Assessment of Full-Length Hepatitis C Viral Genomes
Journal article
Thomson E. et al, (2016), Journal of Clinical Microbiology, 54, 2470 - 2484
T Cell Functionality in Chronic Hepatitis C Patients Treated With the Anti-miR-122 RG-101
Other
Stelma F. et al, (2016), HEPATOLOGY, 64, 731A - 731A
Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection
Journal article
Swadling L. et al, (2016), Vaccines, 4, 27 - 27
Chronic hepatitis C viral infection subverts vaccine‐induced T‐cell immunity in humans
Journal article
Kelly C. et al, (2016), Hepatology, 63, 1455 - 1470
Evaluation of Viremia Frequencies of a Novel Human Pegivirus by Using Bioinformatic Screening and PCR
Journal article
Bonsall D. et al, (2016), Emerging Infectious Diseases, 22, 671 - 678
The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design
Journal article
von Delft A. et al, (2016), Gut, 65, 112 - 123
ve-SEQ: Robust, unbiased enrichment for streamlined detection and whole-genome sequencing of HCV and other highly diverse pathogens
Journal article
Bonsall D. et al, (2015), F1000Research, 4, 1062 - 1062
Apparent spontaneous clearance of chronic hepatitis C virus infection in a HIV co-infected patient with decompensated cirrhosis
Journal article
Mora-Peris B. et al, (2015), AIDS, 29, 982 - 985